Protagen

Protagen is a leading provider of protein research services, products, and software solutions. The company has an experienced and motivated team that delivers high-quality products and services compliant with GMP standards. The UNIcloneA® protein expression library, a patented platform, is one of Protagen's technological innovations. This highly efficient technology platform enables Protagen to develop novel diagnostic technologies based on blood autoantibody signatures. Protagen serves customers worldwide and has offices in Dortmund, Germany, and Chester, New Jersey, USA. Protagen is at the forefront of immunoprofiling and has discovered new autoantibody signatures for autoimmune diseases and immuno-oncology. Protagen’s SeroTag® technology identifies solutions to many challenges currently hindering the successful development and widespread application of cancer immunotherapies and new treatments for autoimmune diseases. The company is a leader in patient stratification for autoimmune diseases and has developed the NavigAID stratification panel, which characterizes individual patients' autoimmune and immune statuses. This precision medicine approach allows for the development and implementation of more targeted disease-specific therapies, such as those for systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), and Sjögren's syndrome (SjSg).